The Journal retracts the article “Differential Regulation of the EGFR/PI3K/AKT/PTEN Pathway between Low- and High-Grade Gliomas” [], cited above.
Following publication, concerns were brought to the attention of the publisher regarding the overlap of images presented in Figure 3.
Adhering to our standard procedure, an investigation was conducted that confirmed indications of inappropriate editing and duplication contained within the Western blots presented in Figure 3 [] and Figure 3C [], produced by a different authorship group.
While the authors cooperated during the investigation, they were unable to satisfactorily explain the overlap nor provide replacement images that meet the required quality standards for original images in order to warrant a correction as per the journal’s original image requirements policy (https://www.mdpi.com/journal/brainsci/instructions#oriimages (accessed on 1 April 2025)). As a result, the Editorial Board and Editor-in-Chief have lost confidence in the reliability of the findings and have decided to retract this paper as per MDPI retraction policy (https://www.mdpi.com/ethics#_bookmark30 (accessed on 1 April 2025)).
This retraction was approved by the Editor-in-Chief of the journal Brain Sciences.
The authors express their disagreement with the decision to retract this article. The authors wish to indicate that the similarities in parts of the Western Blots could be attributed to the fact that the research conducted by Erira et al. (2021) and Wang G et al. (2018) utilized the same standard laboratory technique under similar conditions. This work was previously presented, evaluated, approved, and published at a scientific event in 2013 [].
References
- Erira, A.; Velandia, F.; Penagos, J.; Zubieta, C.; Arboleda, G. RETRACTED: Differential Regulation of the EGFR/PI3K/AKT/PTEN Pathway between Low- and High-Grade Gliomas. Brain Sci. 2021, 11, 1655. [Google Scholar] [CrossRef] [PubMed]
- Wang, G.; Fu, X.-L.; Wang, J.-J.; Guan, R.; Sun, Y.; Tony To, S.-S. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt–MAPK pathway. J. Cell Physiol. 2019, 234, 5888–5903. [Google Scholar] [CrossRef] [PubMed]
- Erira, A.; Penagos, J.; Zubieta, C.; Velandia, F.; Arboleda, H.; Arboleda, G. Regulación diferencial de la vía EGFR/PI3K/AKT/PTEN en gliomas de alto y bajo grado en pacientes colombianos. Rev. Colomb. Cancerol. 2013, 17, 173. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).